GIP may enhance weight loss by directly targeting its receptor in the central nervous system to regulate appetite, enhancing GLP-1s anorectic action, and reducing drug-induced nausea in order to improve the tolerability of and compliance to GLP-1 receptor agonists [45]
Additional information This article is part of the Topical Collection on Pharmacology of Acute Care Rights and permissions About this article Cite this article Alshaya, A., Fanikos, J
Hernndez JA, Barba-Espn G, Diaz-Vivancos P (2017) Glutathione-mediated biotic stress tolerance in plants
Retrieved October 7, 2022
Administration of a second bolus of hexamethonium did not lead to further changes in either heart rate or blood pressure
Free fatty acid increases the expression of NLRP3-caspase1 in adipose tissue macrophages in obese severe acute pancreatitis